5/March/2022 Top Medical Bulletin

Here are top medical stories for today:

Glucose readings now in smartphone with smart glucometers

Technology advances in medicine, a new compact glucometer kit nowadays being used as one of the smartest glucometers. This device can be directly connected to your phone through the jack and is compatible with both Android and iOS. The complete kit includes a smart glucometer device, lancets, glucometer test strips, a lancing pen, a waterproof pouch and a user guide. Its user friendly and pretty much most used device. When all the devices are turning smart, even medical devices are getting innovated. It is capable of instantly transferring the readings of blood sugar levels to your smartphones and share with doctors for online consultancy.

Covid variants remain hidden in the body

Covid -19 stays a trouble despite new researchers, a new study reports a mesmerizing fact about how COVID-19 may have several variants of the virus hidden away from the immune system in different parts of the body. The study, published in the journal Nature Communications, reports how the virus can evolve distinctly over the course of time in different cell types, and adapt its immunity, in the same infected host. The researchers investigated the function of a tailor-made pocket in the SARS- CoV-2 spike protein in the infection cycle of the virus.

Oral immunotherapy induces remission of peanut allergy in some young children

Peanut allergy affects about 2% of children in the United States, or nearly 1.5 million individuals ages 17 years and younger. The results of the IMPACT trial, were published in The Lancet journal has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy.

The immunotherapy consisted of a daily oral dose of peanut flour for 2.5 years. Remission was defined as being able to eat 5 grams of peanut protein, equivalent to 1.5 tablespoons of peanut butter, without having an allergic reaction six months after completing immunotherapy. The youngest children and those who started the trial with lower levels of peanut-specific antibodies were most likely to achieve remission.

Is migraine tied to complications in pregnancy?

Migraine affects health to a greater extent, women with migraine may have a higher risk of pregnancy complications like preterm delivery, gestational high blood pressure and preeclampsia, according to a preliminary study presented at the American Academy of Neurology's 74th Annual Meeting. Researchers also found that women with migraine with aura may have a somewhat higher risk of preeclampsia than women with migraine without aura. Preeclampsia involves high blood pressure with additional symptoms, such as protein in the urine, during pregnancy, which can threaten the life of the mother and baby. Roughly 20% of women of childbearing age experience migraine, but the impact of migraine on pregnancy outcomes still needs further understanding.

Short DAPT Followed by Clopidogrel monotherapy No Better Than Long term DAPT  

Patients with Acute Coronary Syndrome are regarded as having a higher long-term risk of cardiovascular events after percutaneous coronary intervention compared with patients with the chronic coronary syndrome . Therefore, the recommended duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention was longer in patients with Acute Coronary Syndrome than in patients with chronic coronary syndrome. A study published in the JAMA Cardiology suggests that clopidogrel monotherapy after 1 to 2 months of dual antiplatelet therapy is no better than standard 12 months of dual antiplatelet therapy among Acute Coronary Syndrome patients with successful percutaneous coronary intervention.